Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as CMO

January 31, 2018 - Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary Accordion Pill™ platform technology, today announced it has…

Continue Reading Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as CMO